Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Radiation as an immunological adjuvant: current evidence on dose and fractionation
Sandra Demaria, Silvia C. Formenti
Frontiers in Oncology (2012) Vol. 2
Open Access | Times Cited: 305

Showing 1-25 of 305 citing articles:

DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity
Claire Vanpouille‐Box, Amandine Alard, Molykutty J. Aryankalayil, et al.
Nature Communications (2017) Vol. 8, Iss. 1
Open Access | Times Cited: 1448
Prognostic Value of Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancers From Two Phase III Randomized Adjuvant Breast Cancer Trials: ECOG 2197 and ECOG 1199
Sylvia Adams, Robert J. Gray, Sandra Demaria, et al.
Journal of Clinical Oncology (2014) Vol. 32, Iss. 27, pp. 2959-2966
Open Access | Times Cited: 1181
Radiotherapy and immunotherapy: a beneficial liaison?
Ralph R. Weichselbaum, Hua Liang, Liufu Deng, et al.
Nature Reviews Clinical Oncology (2017) Vol. 14, Iss. 6, pp. 365-379
Closed Access | Times Cited: 880
Nanoparticle‐Mediated Immunogenic Cell Death Enables and Potentiates Cancer Immunotherapy
Xiaopin Duan, Christina Chan, Wenbin Lin
Angewandte Chemie International Edition (2018) Vol. 58, Iss. 3, pp. 670-680
Open Access | Times Cited: 858
Combination cancer immunotherapies tailored to the tumour microenvironment
Mark J. Smyth, Shin Foong Ngiow, Antoni Ribas, et al.
Nature Reviews Clinical Oncology (2015) Vol. 13, Iss. 3, pp. 143-158
Closed Access | Times Cited: 845
Cancer nanomedicine for combination cancer immunotherapy
Jutaek Nam, Sejin Son, Kyong Soo Park, et al.
Nature Reviews Materials (2019) Vol. 4, Iss. 6, pp. 398-414
Closed Access | Times Cited: 817
Effect of Pembrolizumab After Stereotactic Body Radiotherapy vs Pembrolizumab Alone on Tumor Response in Patients With Advanced Non–Small Cell Lung Cancer
Willemijn S.M.E. Theelen, Heike Peulen, Ferry Lalezari, et al.
JAMA Oncology (2019) Vol. 5, Iss. 9, pp. 1276-1276
Open Access | Times Cited: 789
Microbiota: a key orchestrator of cancer therapy
Soumen Roy, Giorgio Trinchieri
Nature reviews. Cancer (2017) Vol. 17, Iss. 5, pp. 271-285
Closed Access | Times Cited: 787
Radiation and checkpoint blockade immunotherapy: radiosensitisation and potential mechanisms of synergy
Andrew B. Sharabi, Michael Lim, Theodore L. DeWeese, et al.
The Lancet Oncology (2015) Vol. 16, Iss. 13, pp. e498-e509
Closed Access | Times Cited: 772
Tumour-associated neutrophils in patients with cancer
Merav E. Shaul, Zvi G. Fridlender
Nature Reviews Clinical Oncology (2019) Vol. 16, Iss. 10, pp. 601-620
Closed Access | Times Cited: 758
Role of Local Radiation Therapy in Cancer Immunotherapy
Sandra Demaria, Encouse B. Golden, Silvia C. Formenti
JAMA Oncology (2015) Vol. 1, Iss. 9, pp. 1325-1325
Closed Access | Times Cited: 653
DNA Damage and Repair Biomarkers of Immunotherapy Response
Kent W. Mouw, Michael S. Goldberg, Panagiotis A. Konstantinopoulos, et al.
Cancer Discovery (2017) Vol. 7, Iss. 7, pp. 675-693
Open Access | Times Cited: 581
Safety and Clinical Activity of Pembrolizumab and Multisite Stereotactic Body Radiotherapy in Patients With Advanced Solid Tumors
Jason J. Luke, Jeffrey M. Lemons, Theodore Karrison, et al.
Journal of Clinical Oncology (2018) Vol. 36, Iss. 16, pp. 1611-1618
Open Access | Times Cited: 524
Cancer immunotherapy: Opportunities and challenges in the rapidly evolving clinical landscape
Leisha A. Emens, Paolo A. Ascierto, Phillip K. Darcy, et al.
European Journal of Cancer (2017) Vol. 81, pp. 116-129
Closed Access | Times Cited: 507
Recent Developments in Radiotherapy
Deborah E. Citrin
New England Journal of Medicine (2017) Vol. 377, Iss. 11, pp. 1065-1075
Closed Access | Times Cited: 393
Stereotactic Radiosurgery for Melanoma Brain Metastases in Patients Receiving Ipilimumab: Safety Profile and Efficacy of Combined Treatment
Ana P. Kiess, Jedd D. Wolchok, Christopher A. Barker, et al.
International Journal of Radiation Oncology*Biology*Physics (2015) Vol. 92, Iss. 2, pp. 368-375
Open Access | Times Cited: 367
Current clinical trials testing the combination of immunotherapy with radiotherapy
Josephine Kang, Sandra Demaria, Silvia C. Formenti
Journal for ImmunoTherapy of Cancer (2016) Vol. 4, Iss. 1
Open Access | Times Cited: 354
The linear quadratic model: usage, interpretation and challenges
Stephen J. McMahon
Physics in Medicine and Biology (2018) Vol. 64, Iss. 1, pp. 01TR01-01TR01
Open Access | Times Cited: 333
Randomized Phase II Trial of Nivolumab With Stereotactic Body Radiotherapy Versus Nivolumab Alone in Metastatic Head and Neck Squamous Cell Carcinoma
Sean McBride, Eric J. Sherman, C. Jillian Tsai, et al.
Journal of Clinical Oncology (2020) Vol. 39, Iss. 1, pp. 30-37
Open Access | Times Cited: 330
Radiotherapy: Changing the Game in Immunotherapy
Sandra Demaria, C. Norman Coleman, Silvia C. Formenti
Trends in cancer (2016) Vol. 2, Iss. 6, pp. 286-294
Open Access | Times Cited: 310
Combining Radiation and Immunotherapy: A New Systemic Therapy for Solid Tumors?
Chad Tang, Xiaohong Wang, Hendrick Soh, et al.
Cancer Immunology Research (2014) Vol. 2, Iss. 9, pp. 831-838
Open Access | Times Cited: 306
Activating autophagy to potentiate immunogenic chemotherapy and radiation therapy
Lorenzo Galluzzi, José Manuel Bravo‐San Pedro, Sandra Demaria, et al.
Nature Reviews Clinical Oncology (2016) Vol. 14, Iss. 4, pp. 247-258
Closed Access | Times Cited: 292
Molecular Mechanisms of Radiation-Induced Cancer Cell Death: A Primer
Joseph Sia, Radosław Szmyd, Eric Hau, et al.
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 292
Radiotherapy for renal-cell carcinoma
Gert De Meerleer, Vincent Khoo, Bernard Escudier, et al.
The Lancet Oncology (2014) Vol. 15, Iss. 4, pp. e170-e177
Open Access | Times Cited: 263
Safety of combining radiotherapy with immune-checkpoint inhibition
William L. Hwang, Luke Pike, Trevor J. Royce, et al.
Nature Reviews Clinical Oncology (2018) Vol. 15, Iss. 8, pp. 477-494
Closed Access | Times Cited: 246
Page 1 - Next Page

Scroll to top